Clinical trial
24 Hour IOP Lowering Efficacy of AL-3789
NCT00643669 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24 Hour IOP Lowering Efficacy of AL-3789
- Lead sponsor
- Alcon Research
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- Not reported
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
open-angle glaucoma